Pro Dex Inc (PDEX) Return on Assets ROA from the fourth quarter of 2026 to fourth quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Pro dex Inc   (NASDAQ: PDEX)


Pro Dex Inc 's ROA from the fourth quarter of 2026 to the fourth quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Pro Dex Inc 's ROA in the fourth quarter of 2026?
Pro dex Inc achieved a return on average assets (ROA) of 19.39 % in its fourth quarter of 2026, this is above PDEX's average return on assets of 11.12%.
Pro Dex Inc assets over the 12 months ending in its fourth quarter of 2026 are valued at $70 million

Despite the company's net income deteriorating, Pro Dex Inc was able to improve its ROA compared to the third quarter of 2026.

However, within the Healthcare sector 50 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 260, from total ROA ranking in the third quarter of 2026 at 307.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
IV. Quarter		 (Mar 31 2026)
III. Quarter		 (Dec 31 2025)
II. Quarter		 (Sep 30 2025)
I. Quarter		 (Jun 30 2025)
IV. Quarter
Y / Y Total Assets Change 24.38 % 15.74 % 14.91 % 16.74 % 4.98 %
Y / Y Net Income Change 138.68 % 20.24 % 7.21 % 89.78 % -24.57 %
Net Income (TTM) in million 14 12 11 11 9
Return On Assets (TTM) 19.39 % 18.06 % 17.74 % 18.07 % 15.06 %
PDEX's Total Ranking # 260 # 307 # 270 # 327 # 303
Total Assets (TTM) in million 82 75 61 64 66
Seq. Total Assets Change 9.54 % 21.78 % -5.05 % -1.8 % 1.93 %
Seq. Net Income Change -27.45 % 80.06 % -53.27 % 290.98 % -63.45 %

PDEX's 5 Years Annual ROA >> Back to PDEX Management Effectiveness >> Compare PDEX ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 8
Sector # 51
Overall # 229

Return On Assets Statistics
High Average Low
37.1 %
11.12 %
-15.11 %
(Jun 30 2017)   (Jun 30 2013)





Financial Statements
Pro Dex Inc 's Assets $ 82 million PDEX's Balance sheet
Pro Dex Inc 's Income $ 3 million Quarterly PDEX's Income Statement
PDEX's Income by Division See PDEX's Income by Division



Annual Return On Assets (Jun 30 2026)
FY 2026		 (Jun 30 2025)
FY 2025		 (Jun 30 2024)
FY 2024		 (Jun 30 2023)
FY 2023		 (Jun 30 2022)
FY 2022
Y / Y Total Assets Change 33.07 % 15.19 % 1.12 % 11.27 % 17.38 %
Total Assets in million 82 61 53 53 47
Y / Y Net Income Change 52.17 % 322.1 % -69.93 % 83.5 % -13.37 %
Net Income in million 14 9 2 7 4
Annual Return On Assets 16.74 % 14.64 % 3.99 % 13.43 % 8.15 %

PDEX's 5 Years Annual ROA >> Back to PDEX Management Effectiveness >> Compare PDEX ROA to its Competitors



Comment on PDEX's ROA in the fiscal year ending 2026
In the fiscal year 2026 ROA improved to 16.74 % compared to prior year, due to annual net income growth of 52.17 % to $13.66 million, while value of Pro Dex Inc 's overall assets grew just by 33.07 % to $81.63 million, compared to $81.63 a year before.


More Return On Assets Ratios
PDEX's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PDEX's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PDEX's Competitors
Subscribers only: Roa for Pro Dex Inc 's Suppliers
Subscribers only: Return On Assets for PDEX's Customers

You may also want to know
PDEX's Roi PDEX's Inventory Turnover Ratio PDEX's Growth Rates PDEX's Dividend Comparisons
PDEX's Profitability Ratios PDEX's Asset Turnover Ratio PDEX's Dividend Growth
PDEX's Roe PDEX's Valuation Ratios PDEX's Financial Strength Ratios PDEX's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA
Lensar Inc   47.48 %
Elite Pharmaceuticals Inc   46.11 %
Omeros Corporation  46.05 %
Q32 Bio Inc   45.18 %
Aurinia Pharmaceuticals Inc   44.95 %
Agenus Inc  44.86 %
Earth Science Tech Inc   44.02 %
Liquidia Corporation  36.30 %
Ironwood Pharmaceuticals inc   34.34 %
Idexx Laboratories Inc  33.61 %
Tg Therapeutics Inc   33.59 %
Meiragtx Holdings Plc  29.37 %
Indivior Pharmaceuticals Inc   28.21 %
Qhslab Inc   27.12 %
Adma Biologics Inc   26.58 %
Mettler toledo International Inc   24.86 %
Medpace Holdings Inc   24.84 %
Caredx Inc   24.81 %
Acadia Pharmaceuticals Inc   24.38 %
Eli Lilly And Company  21.97 %
Innoviva Inc   21.64 %
Vaxart Inc   20.85 %
Zevra Therapeutics Inc   20.39 %
Iradimed Corporation  20.36 %
Protalix Biotherapeutics inc   20.09 %
Pro dex Inc   19.87 %
Electromed Inc   19.39 %
United Therapeutics Corporation  17.98 %
Resmed Inc   17.80 %
Krystal Biotech Inc   17.65 %

Date modified: 2026-09-05T07:51:00+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.